| Trial ID: | L1896 |
| Source ID: | NCT01906294
|
| Associated Drug: |
Antidiabetic Treatment (Atc A10b)
|
| Title: |
IMS® DIAREG Diabetes Registry - Prospective Diabetes Registry of Patients With Type 2 Diabetes Mellitus
|
| Acronym: |
|
| Status: |
TERMINATED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes Mellitus
|
| Interventions: |
DRUG: antidiabetic treatment (ATC A10B)
|
| Outcome Measures: |
Primary: routine treatment data (composite of e.g. diagnostics, kind and dosage of pharmacological diabetes treatment), The objective of the project is to develop a sustainable Type 2 Diabetes Mellitus (T2DM) registry to collect daily routine treatment data (e.g. diagnostics, kind and dosage of pharmacological diabetes treatment) to provide a better understanding of the disease specific epidemiology, treatment patterns, patient relevant outcomes, patient subgroups, specifically among patients with Type 2 Diabetes Mellitus. Further DDG ("Deutsche Diabetes Gesellschaft") guideline adherence and economic aspects of diabetes treatment should be evaluated on the basis of this registry data., From date of registration every 3 months until end of study (up to 120 months) |
|
| Sponsor/Collaborators: |
Sponsor: IMS HEALTH GmbH & Co. OHG
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
2104
|
| Study Type: |
OBSERVATIONAL
|
| Study Designs: |
Observational Model: |Time Perspective: p
|
| Start Date: |
2013-08
|
| Completion Date: |
2016-03
|
| Results First Posted: |
|
| Last Update Posted: |
2016-04-11
|
| Locations: |
Praxis Dr. med. Birgit Böttger, Frankfurt am Main, 60325, Germany
|
| URL: |
https://clinicaltrials.gov/show/NCT01906294
|
